Pathway name: | p53 signaling pathway |
Aging Type: | Accelerate |
Aging characteristic: | cellular senescence |
Category: | pathway |
Phenotype: | Systemic lupus erythematosus |
Experiment: | Western blot//SA-β-gal activity assay//Colony formation assay |
Description: | We found that the expressions of p53 and p21 were increased in the BM-MSCs from SLE patients.MSCs declined by about a quarter in SLE patients compared to normal group , P < 0.05) indicating that the capability of replicating and forming colonies of BM-MSCs from SLE patients were decreased. Furthermore, we have found that the number of SA-β-gal-positive cells was notably increased in BM-MSCs from SLE patients, which was used to examine MSCs senescence. |
Pathway name | Pathway source | Gene number | Edge number | Geneset |
---|---|---|---|---|
p53 signaling pathway | kegg | 66 | 297 | SESN2;RFWD2;MDM4;CASP9;GADD45A;SFN;TP73;RPRM;STEAP3;TP53I3;RRM2;CASP8;SHISA5;ATR;ZMAT3;CCNG2;RCHY1;CASP3;CCNG1;CCNB1;CCND3;PERP;CDKN1A;SESN1;CYCS;SERPINE1;IGFBP3;CDK6;BAI1;CCNE2;RRM2B;GADD45G;CDKN2A;FAS;CDK1;PTEN;CCNB3;EI24;LRDD;ATM;TP53AIP1;DDB2;CHEK1;SESN3;CD82;CCND1;CCND2;CDK4;IGF1;CDK2;APAF1;MDM2;CCNB2;SIAH1;TSC2;PPM1D;TP53;SERPINB5;PMAIP1;GADD45B;CCNE1;BAX;BBC3;CHEK2;GTSE1;BID |